Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer
British Journal of Cancer, Published online: 20 September 2023; doi:10.1038/s41416-023-02427-3Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 20, 2023 Category: Cancer & Oncology Authors: Masayuki Shirasawa Tatsuya Yoshida Kouya Shiraishi Naoko Goto Shigehiro Yagishita Tatsuya Imabayashi Yuji Matsumoto Ken Masuda Yuki Shinno Yusuke Okuma Yasushi Goto Hidehito Horinouchi Masaya Yotsukura Yukihiro Yoshida Kazuo Nakagawa Katsuhiko Naoki Takaa Source Type: research

A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
British Journal of Cancer, Published online: 20 September 2023; doi:10.1038/s41416-023-02431-7A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 20, 2023 Category: Cancer & Oncology Authors: Daphne Day John J. Park Jermaine Coward Ben Markman Charlotte Lemech James C. Kuo Amy Prawira Michael P. Brown Sarwan Bishnoi Dusan Kotasek R. Matthew Strother Rasha Cosman Rila Su Yiding Ma Zenglian Yue Hui-han Hu Rachel Wu Peiqi Li Archie N. Tse Source Type: research

Heat-shock protein 90α protects NME1 against degradation and suppresses metastasis of breast cancer
British Journal of Cancer, Published online: 20 September 2023; doi:10.1038/s41416-023-02435-3Heat-shock protein 90α protects NME1 against degradation and suppresses metastasis of breast cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 20, 2023 Category: Cancer & Oncology Authors: Yanchao Zhang Guomeng Zhao Liting Yu Xindong Wang Yao Meng Jinlei Mao Ziyi Fu Yongmei Yin Jinyao Li Xun Wang Changying Guo Source Type: research

Years of life lost due to cancer in the United Kingdom from 1988 to 2017
British Journal of Cancer, Published online: 19 September 2023; doi:10.1038/s41416-023-02422-8Years of life lost due to cancer in the United Kingdom from 1988 to 2017 (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 19, 2023 Category: Cancer & Oncology Authors: Amar S. Ahmad Judith Offman Christine Delon Bernard V. North Jon Shelton Peter D. Sasieni Source Type: research

Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage
British Journal of Cancer, Published online: 19 September 2023; doi:10.1038/s41416-023-02434-4Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 19, 2023 Category: Cancer & Oncology Authors: Matthew E. J. Callister Emma J. Crosbie Philip A. J. Crosbie Hilary A. Robbins Source Type: research

Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives
British Journal of Cancer, Published online: 19 September 2023; doi:10.1038/s41416-023-02429-1Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 19, 2023 Category: Cancer & Oncology Authors: Claire E. Wakefield Kate Hetherington Eden G. Robertson Mark W. Donoghoe Jacqueline D. Hunter Janine Vetsch Jonathan M. Marron Katherine M. Tucker Glenn M. Marshall Alexander Broom Michelle Haber Vanessa Tyrrell David Malkin Loretta Lau Marion K. Mateos T Source Type: research

Increased MCL1 dependency leads to new applications of BH3-mimetics in drug-resistant neuroblastoma
British Journal of Cancer, Published online: 19 September 2023; doi:10.1038/s41416-023-02430-8Increased MCL1 dependency leads to new applications of BH3-mimetics in drug-resistant neuroblastoma (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 19, 2023 Category: Cancer & Oncology Authors: Maureen Jacob Sara Wiedemann Daniela Br ücher Nadja M. Pieper Moni Birkhold Vinzenz S ärchen Jan Jeroch Melanie C. Demes Steffen Gretser Yannick Braun Elise Gradhand Florian Rothweiler Martin Michaelis Jindrich Cinatl Jr Meike Vogler Source Type: research

Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets
British Journal of Cancer, Published online: 19 September 2023; doi:10.1038/s41416-023-02425-5Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 19, 2023 Category: Cancer & Oncology Authors: Felix Bremmer Pailin Pongratanakul Margaretha Skowron Yue Che Annika Richter Stefan K üffer Kirsten Reuter-Jessen Hanibal Bohnenberger Stella Pauls Catena Kresbach Ulrich Sch üller Kai St ühler Philipp Str öbel Peter Albers Daniel Nettersheim Source Type: research

Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo
British Journal of Cancer, Published online: 18 September 2023; doi:10.1038/s41416-023-02433-5Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 18, 2023 Category: Cancer & Oncology Authors: N. Gassler C. Zhang T. Wenger P. A. Schnabel H. Dienemann K. -M Debatin J. Mattern I. Herr Source Type: research

A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
British Journal of Cancer, Published online: 16 September 2023; doi:10.1038/s41416-023-02423-7A spectroscopic liquid biopsy for the earlier detection of multiple cancer types (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 16, 2023 Category: Cancer & Oncology Authors: James M. Cameron Alexandra Sala Georgios Antoniou Paul M. Brennan Holly J. Butler Justin J. A. Conn Siobhan Connal Tom Curran Mark G. Hegarty Rose G. McHardy Daniel Orringer David S. Palmer Benjamin R. Smith Matthew J. Baker Source Type: research

The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer
British Journal of Cancer, Published online: 15 September 2023; doi:10.1038/s41416-023-02432-6The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 15, 2023 Category: Cancer & Oncology Authors: Jie Mei Yun Cai Lingyan Chen Youqing Wu Jiayu Liu Zhiwen Qian Ying Jiang Ping Zhang Tiansong Xia Xiang Pan Yan Zhang Source Type: research

BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARγ/PDK1 dependent manner
British Journal of Cancer, Published online: 15 September 2023; doi:10.1038/s41416-023-02418-4BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARγ/PDK1 dependent manner (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 15, 2023 Category: Cancer & Oncology Authors: Qian Wang Ning Liang Chaoxu Liu Jing Li Yaxing Bai Shuanghong Lei Qian Huang Ligang Sun Liangke Tang Chao Zeng Yuqun Tang Xianli He Tao Yang Gang Wang Source Type: research

Histological diagnosis of polyploidy discriminates an aggressive subset of hepatocellular carcinomas with poor prognosis
British Journal of Cancer, Published online: 15 September 2023; doi:10.1038/s41416-023-02408-6Histological diagnosis of polyploidy discriminates an aggressive subset of hepatocellular carcinomas with poor prognosis (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 15, 2023 Category: Cancer & Oncology Authors: Takanori Matsuura Yoshihide Ueda Yoshiyuki Harada Kazuki Hayashi Kisara Horisaka Yoshihiko Yano Shinichi So Masahiro Kido Takumi Fukumoto Yuzo Kodama Eiji Hara Tomonori Matsumoto Source Type: research

Correction: Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada
British Journal of Cancer, Published online: 13 September 2023; doi:10.1038/s41416-023-02415-7Correction: Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 13, 2023 Category: Cancer & Oncology Authors: Sierra Cheng John R. McLaughlin M. Catherine Brown Hamad Al-Sawaihey James Rutka Eric Bouffet Cynthia Hawkins A. Elizabeth Cairney Adrianna Ranger Adam J. Fleming Donna Johnston Mark Greenberg David Malkin Rayjean J. Hung Source Type: research

The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review
British Journal of Cancer, Published online: 12 September 2023; doi:10.1038/s41416-023-02424-6The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review (Source: British Journal of Cancer)
Source: British Journal of Cancer - September 12, 2023 Category: Cancer & Oncology Authors: Zexi Allan Sasha Witts Jeanne Tie Niall Tebbutt Nicholas J. Clemons David S. Liu Source Type: research